Abstract
Background: The Covid-19 pandemic may have a deleterious impact on patients with autoimmune systemic diseases (ASD) due to their deep immune-system alterations.
Objective: This study aims to investigate the prevalence of symptomatic Covid-19 and its correlations with both organ involvement and ongoing treatments in a large series of Italian ASD patients during the first wave of pandemic.
Methods: Our multicenter telephone 6-week survey included 3,029 unselected ASD patients enrolled at 36 tertiary referral centers of northern, central, and southern Italian macro-areas with different diffusion of the pandemic. Symptomatic SARS-CoV-2 infection was classified as definite Covid-19 (presence of symptoms plus positive oral/nasopharyngeal swabs) or highly suspected Covid-19 (highly suggestive symptoms, in the absence of a swab testing).
Results: A significantly higher prevalence of definite plus highly suspected Covid-19 compared to the Italian general population was detected in the whole ASD series (p=.000), as well as in patients from the three macro-areas (p=.000 in all). Statistically higher prevalence of Covid-19 was also found in connective tissue diseases compared to chronic arthritis subgroup (p=.000) and in ASD patients with pre-existing interstitial lung involvement (p=.000). Patients treated with either conventional disease-modifying anti-rheumatic drugs (DMARDs) and/or biological DMARDs showed a significantly lower prevalence of Covid-19 (p=.000 in both). Finally, scleroderma patients undergoing low-dose aspirin showed a significantly lower rate of Covid-19 compared to those without (p=0.003).
Conclusion: The higher prevalence of Covid-19 in ASD patients, along with the significant correlations with important clinical features and therapeutic regimens, suggests the need to develop targeted prevention/management strategies during the current pandemic wave.
Keywords: Covid-19, SARS-CoV-2, autoimmune systemic diseases, rheumatic diseases, arthritis, connective tissue diseases, systemic sclerosis, interstitial lung disease.
Current Pharmaceutical Design
Title:Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
Volume: 27 Issue: 41
Author(s): Clodoveo Ferri*, Dilia Giuggioli, Vincenzo Raimondo, Massimo L’Andolina, Lorenzo Dagna, Antonio Tavoni, Francesco Caso, Francesco Ursini, Piero Ruscitti , Maurizio Caminiti, Rosario Foti, Valeria Riccieri , Serena Guiducci, Roberta Pellegrini, Elisabetta Zanatta, Giuseppe Varcasia, Domenico Olivo, Pietro Gigliotti, Giovanna Cuomo, Giuseppe Murdaca, Riccardo Cecchetti, Rossella De Angelis, Nicoletta Romeo, Francesca Ingegnoli, Franco Cozzi, Veronica Codullo, Ilaria Cavazzana, Michele Colaci, Giuseppina Abignano, Maria De Santis, Ennio Lubrano, Enrico Fusaro, Alessandra Della Rossa, Amelia Spinella, Federica Lumetti, Giacomo De Luca, Silvia Bellando-Randone, Elisa Visalli, Ylenia Dal Bosco, Giorgio Amato, Daiana Giannini, Silvia Bilia, Francesco Masini, Greta Pellegrino, Erika Pigatto, Elena Generali, Giuseppa Pagano Mariano, Giorgio Pettiti, Giovanni Zanframundo, Raffaele Brittelli, Vincenzo Aiello, Rodolfo Caminiti, Daniela Scorpiniti, Tommaso Ferrari, Corrado Campochiaro, Veronica Brusi, Micaela Fredi, Liala Moschetti, Fabio Cacciapaglia, Laura Gragnani, Monica Monti, Serena Lorini, Sabrina Rosaria Paparo, Francesca Ragusa, Valeria Mazzi, Giusy Elia, Silvia Martina Ferrari, Ilenia Di Cola, Marta Vadacca, Sebastiano Lorusso, Simone Barsotti, Maria Letizia Aprile, Tasso Marco, Mario Miccoli , Silvia Bosello, Marco Matucci-Cerinic, Salvatore D'Angelo, Andrea Doria, Franco Franceschini, Riccardo Meliconi, Florenzo Iannone, Roberto Giacomelli, Anna Linda Zignego, Poupak Fallahi and Alessandro Antonelli*
Affiliation:
- Rheumatology Unit, University of Modena and Reggio Emilia, School of Medicine, Modena,Italy
- Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, School of Medicine, Pisa,Italy
Keywords: Covid-19, SARS-CoV-2, autoimmune systemic diseases, rheumatic diseases, arthritis, connective tissue diseases, systemic sclerosis, interstitial lung disease.
Abstract:
Background: The Covid-19 pandemic may have a deleterious impact on patients with autoimmune systemic diseases (ASD) due to their deep immune-system alterations.
Objective: This study aims to investigate the prevalence of symptomatic Covid-19 and its correlations with both organ involvement and ongoing treatments in a large series of Italian ASD patients during the first wave of pandemic.
Methods: Our multicenter telephone 6-week survey included 3,029 unselected ASD patients enrolled at 36 tertiary referral centers of northern, central, and southern Italian macro-areas with different diffusion of the pandemic. Symptomatic SARS-CoV-2 infection was classified as definite Covid-19 (presence of symptoms plus positive oral/nasopharyngeal swabs) or highly suspected Covid-19 (highly suggestive symptoms, in the absence of a swab testing).
Results: A significantly higher prevalence of definite plus highly suspected Covid-19 compared to the Italian general population was detected in the whole ASD series (p=.000), as well as in patients from the three macro-areas (p=.000 in all). Statistically higher prevalence of Covid-19 was also found in connective tissue diseases compared to chronic arthritis subgroup (p=.000) and in ASD patients with pre-existing interstitial lung involvement (p=.000). Patients treated with either conventional disease-modifying anti-rheumatic drugs (DMARDs) and/or biological DMARDs showed a significantly lower prevalence of Covid-19 (p=.000 in both). Finally, scleroderma patients undergoing low-dose aspirin showed a significantly lower rate of Covid-19 compared to those without (p=0.003).
Conclusion: The higher prevalence of Covid-19 in ASD patients, along with the significant correlations with important clinical features and therapeutic regimens, suggests the need to develop targeted prevention/management strategies during the current pandemic wave.
Export Options
About this article
Cite this article as:
Ferri Clodoveo *, Giuggioli Dilia , Raimondo Vincenzo , L’Andolina Massimo, Dagna Lorenzo , Tavoni Antonio, Caso Francesco , Ursini Francesco , Ruscitti Piero, Caminiti Maurizio , Foti Rosario , Riccieri Valeria , Guiducci Serena , Pellegrini Roberta , Zanatta Elisabetta, Varcasia Giuseppe , Olivo Domenico , Gigliotti Pietro, Cuomo Giovanna , Murdaca Giuseppe , Cecchetti Riccardo , De Angelis Rossella, Romeo Nicoletta , Ingegnoli Francesca, Cozzi Franco , Codullo Veronica , Cavazzana Ilaria , Colaci Michele, Abignano Giuseppina, De Santis Maria , Lubrano Ennio, Fusaro Enrico , Rossa Della Alessandra , Spinella Amelia , Lumetti Federica, De Luca Giacomo , Bellando-Randone Silvia , Visalli Elisa, Dal Bosco Ylenia , Amato Giorgio, Giannini Daiana , Bilia Silvia , Masini Francesco, Pellegrino Greta , Pigatto Erika, Generali Elena , Mariano Pagano Giuseppa , Pettiti Giorgio , Zanframundo Giovanni , Brittelli Raffaele, Aiello Vincenzo , Caminiti Rodolfo , Scorpiniti Daniela , Ferrari Tommaso , Campochiaro Corrado , Brusi Veronica, Fredi Micaela, Moschetti Liala , Cacciapaglia Fabio , Gragnani Laura , Monti Monica , Lorini Serena , Paparo Rosaria Sabrina, Ragusa Francesca , Mazzi Valeria , Elia Giusy, Ferrari Martina Silvia, Di Cola Ilenia , Vadacca Marta, Lorusso Sebastiano , Barsotti Simone , Aprile Letizia Maria, Marco Tasso , Miccoli Mario , Bosello Silvia , Matucci-Cerinic Marco , D'Angelo Salvatore , Doria Andrea , Franceschini Franco , Meliconi Riccardo , Iannone Florenzo, Giacomelli Roberto , Zignego Linda Anna, Fallahi Poupak and Antonelli Alessandro *, Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments, Current Pharmaceutical Design 2021; 27 (41) . https://dx.doi.org/10.2174/1381612827666210903103935
DOI https://dx.doi.org/10.2174/1381612827666210903103935 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis and Preliminary COX-2 Expression Inhibitory Activities of Andrographolide Derivatives
Letters in Drug Design & Discovery Inhibitors of the HSP90 Molecular Chaperone: Attacking the Master Regulator in Cancer
Current Topics in Medicinal Chemistry Chemistry and Anticancer Activity of Hybrid Molecules and Derivatives based on 5-Fluorouracil
Current Medicinal Chemistry Novel Synthetic Strategies for the Development of Tryptophan-Proline Chimeras, Useful Tool for Drug Discovery
Current Bioactive Compounds A Review on PCR and POC-PCR - A Boon in the Diagnosis of COVID-19
Current Pharmaceutical Analysis What we have Learned from Animal Models of Mycoplasma pneumoniae Disease: Virulence Mechanisms and Host Responses
Current Pediatric Reviews Systemic Approach to Parenteral Nutrition in the ICU
Current Drug Safety Abscisic Acid: A Versatile Phytohormone in Plant Signaling and Beyond
Current Protein & Peptide Science Cyanosis Due to Methemoglobinemia Induced by Topical Anesthesia in a Premature Infant
Current Drug Therapy Review of Synthesis, Assay, and Prediction of β and γ-secretase Inhibitors
Current Topics in Medicinal Chemistry Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Concurrence of Talaromycosis and Kaposi Sarcoma in an HIV-Infected Patient: A Case Report
Current HIV Research Generating a Biological Pacemaker - Tackling Arrhythmias the Stem Cell Way
Recent Patents on Regenerative Medicine Vitamin D and Vitamin D Analogs in Cancer Treatment
Current Drug Targets Anti-inflammatory Effects of Dietary Antioxidants
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Prediction of Carcinogenicity from Molecular Structure
Current Computer-Aided Drug Design An Overview of Thrombin Inhibitors in the Perspective of Structureactivity Relationships
Current Medicinal Chemistry Isolation, Synthesis and Medicinal Significance of Marine Pyridoacridine Alkaloids
Current Organic Chemistry Investigation of the Dyeing Ability of Some Reactive Triazine Azo Dyes Containing Pyrazole Fragment
Current Organic Synthesis Hydrazides as Potential HDAC Inhibitors: Structure-activity Relationships and Biological Implications
Current Topics in Medicinal Chemistry